NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
via Google News
The Latest on: Inflammation therapy
- Magenta Therapeutics up 3% premarket on updated cell therapy dataon February 20, 2020 at 11:17 am
Thinly traded Magenta Therapeutics (NASDAQ:MGTA) is up 3% premarket on light volume in reaction to updated data from a Phase 2 clinical trial evaluating cell therapy MGTA-456 in patients with severe .
- Bone Marrow Transplant Can Replace Overactive Immune Cells, Preventing Inflammation in MS, Study Sayson February 20, 2020 at 6:25 am
“Taken together, our findings support the hypothesis that AHSCT therapy removes the majority ... including pathogenic [inflammatory] T cells, and induces the generation of a newly differentiated ...
- Mesothelioma Gene Therapy Trial Shows ‘Real Potential’on February 19, 2020 at 10:43 am
The phase III trial, known as the INFINITE clinical research study, is designed to evaluate the intrapleural delivery of an investigational drug — a type of gene therapy — in combination with ...
- New mechanism involved in senescence modulates inflammation, response to immunotherapyon February 19, 2020 at 3:04 am
Senescent cells also represent a trigger of inflammation and immune reaction as they produce an array of inflammatory ... The authors went on to establish that the HMGB2-TOP1cc-cGAS pathway is ...
- Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptideson February 19, 2020 at 2:26 am
the side effects can result in therapy stop, which makes the effectiveness of treatment strategies limited. Therefore, it is urgent and necessary to develop novel therapeutics. Here, we investigated ...
- Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescenceon February 19, 2020 at 2:25 am
cGAS promotes inflammatory senescence-associated secretory phenotype (SASP ... Functionally, the HMGB2-TOP1cc-cGAS axis determines the response of orthotopically transplanted ex vivo therapy-induced ...
- Periodontal Therapy and Inflammation in Dialysis Patientson February 16, 2020 at 10:08 pm
Background: This systematic review aimed to investigate whether non-surgical periodontal therapy (NSPT) can reduce systemic inflammatory levels and improve metabolism in patients undergoing ...
- Menopause Hormone Therapy Found to Delay Type 2 Diabeteson February 16, 2020 at 9:21 pm
In women with diabetes, hormone therapy reduced fasting glucose by 11% and HOMA-IR by 36%. The mechanisms by which estrogens improve glucose homeostasis are yet to be fully understood. "One of the ...
- Antech completes final study of first diagnostic for inflammatory bowel diseaseon February 14, 2020 at 6:00 am
/PRNewswire/ -- Today, Antech Diagnostics, part of Mars Petcare, completed a final study of its new blood test for inflammatory bowel disease (IBD), also ...
via Bing News